Conference Coverage

VIDEO: Ankylosing spondylitis problems outside the joints strike more women than men


 

AT THE ACR ANNUAL MEETING

– Women are almost twice as likely as men to develop extra-articular manifestations of ankylosing spondylitis such as uveitis and inflammatory bowel disease, according to an analysis of patients in the Ankylosing Spondylitis Registry of Ireland.

Each of those manifestations exerts its own difficulties upon patients over and above the inflammatory back pain of the underlying disease, Gillian Fitzgerald, MD, said at the annual meeting of the American College of Rheumatology. Many patients can develop several of these separate manifestations – a circumstance that seriously affects their quality of life.

The findings of the large registry study were a bit surprising, she said during presentation of the study at a press briefing, as ankylosing spondylitis is generally thought to affect largely men. “However, this isn’t the case,” said Dr. Fitzgerald of St. James’s Hospital, Dublin. “Recent studies show that women can be affected as often as men are.”

In light of those findings, Dr. Fitzgerald and her coauthors wanted to further define the gender differences, especially with regard to extra-articular manifestations.

They accessed data on 564 patients in the registry, which was established in 2013. The majority of patients (78%) were men; the mean age was 47 years. Patients had a mean disease duration of nearly 21 years. For almost half that time (9 years) they had remained undiagnosed, Dr. Fitzgerald added. They had a mean age of about 47 years, and 78% fulfilled the modified New York criteria for ankylosing spondylitis.

Overall, extra-articular manifestations were common, with 35% having uveitis, 18% psoriasis, and 10% inflammatory bowel disease.

Uveitis was significantly more common among women (47% vs. 32%) and among those with disease duration of more than 10 years (40% vs. 22% with less than 10 years).

Inflammatory bowel disease was also significantly more common among women (16.5% vs. 8%). It wasn’t related to disease duration, but it was related to elevated baseline C-reactive protein, peptic ulcer disease, and osteoporosis.

In a multivariate regression analysis, women were 70% more likely to experience an extra-articular manifestation of the disease than were men (hazard ratio, 1.7). Having the disease for more than 10 years more than doubled the risk of an extra-articular manifestation (HR, 2.4).

Dr. Fitzgerald discussed the study’s findings in a video interview at the meeting. She had no financial disclosures.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

On Twitter @alz_gal

Recommended Reading

Most children with JIA get different diagnosis as adults
MDedge Family Medicine
Severe joint pain in adults with arthritis continues to rise
MDedge Family Medicine
FDA approves biosimilar adalimumab
MDedge Family Medicine
Biosimilars face barriers to broader acceptance
MDedge Family Medicine
FDA’s Woodcock: Give biosimilars a chance
MDedge Family Medicine
Study offers reassuring data on certolizumab use in pregnancy
MDedge Family Medicine
VIDEO: Biologics: Proposed guideline addresses perioperative management
MDedge Family Medicine
Infliximab biosimilar posts mostly reassuring data in Norway’s NOR-SWITCH study
MDedge Family Medicine
Breast milk doesn’t contain meaningful levels of certolizumab pegol
MDedge Family Medicine
VIDEO: Statins cut mortality in ankylosing spondylitis, psoriatic arthritis
MDedge Family Medicine